Of those, higher levels of nine biomarkers (CCL4, CCL20, CD5, CD6, CD244, IL-10RB, LIF-R, SLAMF1, uPA) were associated with lower CES-D reductions in people with type 1 diabetes. This evidence concerns the gene CD5 and type 1 diabetes mellitus.